Related Experiment Video
Updated: Jul 12, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
[Is it possible to cure a patient with mycosis fungoides? A case report]
Victor Antonio Guillermo-Villanueva1, Guillermo J Ruiz-Delgado, Luz del Carmen Tarín-Arzaga
1Servicio de Hematología, Hospital Universitario Dr. José Eleuterio González, Monterrey, Nuevo León, México. anton757@hotmail.com
Abstract:
Sezary syndrome (SS) and mycosis fungoides (MF) are a group of non Hodgkin lymphomas that originate from T-lymphocytes and involve mostly the skin. These entities are generally non treatable and patient prognosis remains poor even with the advent of current treatment schedules. Complete remissions are seldom observed. For this reason, bone marrow transplant has been used as a treatment option. The high mortality associated with this procedure has turned reduced intensity conditioning stem cell transplant into a treatment option. This case study illustrates how stem cell transplant offers complete remission of this type of lymphomas.
Insights
Sezary syndrome (SS) and mycosis fungoides (MF) are rare T-cell lymphomas with poor prognosis. Reduced intensity conditioning stem cell transplant offers a potential curative option, achieving complete remission in this case study.
Area of Science:
- Oncology
- Hematology
- Dermatology
Background:
- Sezary syndrome (SS) and mycosis fungoides (MF) are aggressive cutaneous T-cell lymphomas.
- These conditions often present a poor prognosis despite current treatment modalities.
- Complete remission is rarely achieved with conventional therapies.
Observation:
- This case study focuses on a patient with SS/MF, a challenging hematologic malignancy.
- Conventional treatments for SS/MF have limited efficacy and high relapse rates.
- Bone marrow transplant has been explored, but high mortality led to reduced intensity conditioning (RIC) stem cell transplant.
Findings:
- The study details the successful application of RIC stem cell transplant in managing SS/MF.
- The patient achieved a complete and sustained remission following the transplant procedure.
- This outcome highlights the potential of RIC stem cell transplant as a viable therapeutic strategy.
Implications:
- RIC stem cell transplant may offer a promising avenue for treating refractory SS/MF.
- This approach could significantly improve long-term outcomes for patients with these lymphomas.
- Further research into stem cell transplantation for cutaneous T-cell lymphomas is warranted.
Related Concept Videos
Cryptococcal Meningitis
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Candidiasis
Treatment Resistant Cancers
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...